D-0242-2017 Class II Terminated
FDA drug recall D-0242-2017 was initiated by Gentell, Inc on Dec 15, 2016 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 16, 2018). Affected quantity: 3,000 gauzes.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 11, 2017
- Initiation Date
- Dec 15, 2016
- Termination Date
- Feb 16, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,000 gauzes
Product description
Gentell Hydrogel Ag Saturated Gauze, 2"x2"(NDC 61551-112-20), 4x4(NDC 61554-114-24) and 4"x8"(NDC 61554-118-28), Manufactured by: Gentell, 2701 Bartram Road, Bristol, PA 19007
Reason for recall
CGMP Deviations
Distribution pattern
United States
Code information
Gentell Hydrogel AG 2X2 (Gen-11260) Lot #: 1121615, 1121713, 1122215; Exp. 11/18 Gentell Hydrogel AG 4X4 (Gen-11460) Lot #: 1123315, 1125215, 1126515; Exp. 11/18 Gentell Hydrogel AG 4X8 (Gen-11860) Lot #: 1127315, 1130015, 1133615; Exp. 11/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0242-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026